Related Experiment Video
Updated: Sep 18, 2025

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model
Published on: October 31, 2010
Lenacapavir: a potential game changer for HIV prevention in the Americas, if the game is played equitably
Valeria D Cantos1,2, Brenda Crabtree Ramírez3, Colleen F Kelley1,2
1Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, USA.
Abstract:
Lenacapavir, a first in class long-acting capsid inhibitor has near 100% efficacy in preventing HIV. As such, it has the potential to curb the rising HIV incidence in Latin America, a region with stark intra- and inter-country PrEP uptake disparities. In this viewpoint, we summarize the current efforts to scale up lenacapavir access globally and the necessary steps to include Latin America in these endeavours.
Related Concept Videos
Retrovirus Life Cycles
Retroviruses
Subviral Agents

